Senzime AB, a biotechnological company, engages in the development and marketing of enzyme based biosensor technology products in Sweden. Its technology is used in the applications of medical and biochemical processes, industries, and other areas. The company offers BioSenz, a product platform that optimizes bioprocesses by continuous measurements of the glucose or lactate concentration in the bioreactor where the measured value can be used for control of the process. It also provides BioSenz auxiliaries, such as SFP1, a special filter unit that collects samples from cultures or fermentations; MP4, a multiplexer unit for monitoring various bioreactors; ACOD, an analog output unit that is mounted on the back of BioSenz for reducing bench space; and other accessories comprising calibration and buffer solutions. Senzime AB was founded in 1997 and is headquartered in Uppsala, Sweden.
(SEZI:AktieTorget Stock Exchange)
Uppsala, 756 51
Phone: 46 18 51 56 40
Fax: 46 18 51 56 30www.senzime.com
|No competitor information is available for SEZI.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact SENZIME AB, please visit www.senzime.com. Company data is provided by Capital IQ. Please use this form to report any data issues.